Antiparkinsonian medication "Madopar": instructions for use

Medopar Medication instructions for use describe how a combined remedy for the treatment of Parkinson's disease. Admission of this drug effectively removes muscle rigidity, hypokinesia and dysphagia. In addition, the medicine "Madopar" quickly copes with salivation and tremor. The pronounced effect of using this antiparkinsonian drug is noted six to eight days after the beginning of the admission, and the maximum result is in twenty-five to thirty days. It should be especially noted that this medicine stimulates the evacuation of the stomach contents, which ultimately allows reaching its maximum concentration in the plasma in only three hours.

The combined product "Madopar" (the instruction on application is necessarily included) is produced in the form of tablets, instant tablets and capsules. The latter have a hard gelatin structure and a pink-blue body.

Each capsule contains levodopa and benserazide, which act as active components. Tablets "Madopar" are flat-cylindrical dragees of pale red color with a weak odor. They also contain substances such as levodopa and benserazide.

To write out the combined preparation "Madopar" the instruction on application advises basically for the treatment of people suffering from Parkinson's disease. In addition, this tool is often prescribed for the purpose of eliminating restless legs syndrome. Finally, use this medication is recommended for people with kidney failure.

As for the main contraindications, the instructions for use of Madopar tablets and capsules strictly prohibit those patients who have serious heart diseases, angle-closure glaucoma or mental disorders. In addition, doctors do not recommend the use of this anti-Parkinsonian drug in the case of decompensated disruption of the liver, kidney or endocrine system. Also, it is strictly forbidden to prescribe this medicine to people under twenty-five years of age.

In case the patient has an allergic reaction to levodopa or benserazide, likewise, it is not necessary to start taking Madopar tablets. Feedback, like the instruction, suggests the undesirability of prescribing this combination drug to people with bronchial asthma. With great care to take this anti-Parkinsonian remedy is necessary for patients with active peptic ulcer. Use the drug "Madopar" should not be and in the case of severe oppression of bone marrow hematopoiesis, melanoma, pregnancy or osteomalacia. The lactation period, arrhythmia and myocardial infarction are also included in the list of direct contraindications.

In addition to all of the above, it should be said about the possible side effects and unwanted reactions, which can be provoked by the reception of Madopar tablets. So, for example, in the first days of treatment, sometimes a decrease in appetite, pain in epigastrium, dysphagia and vomiting. There is also a small risk of developing orthostatic hypotension, thrombocytopenia, leukopenia, hemolytic anemia or tachycardia. In addition, some patients complain of depression, sleep disorders, insomnia, constipation and weight gain.